Passive Protection of Rabbits Infected with Toxic Shock Syndrome-Associated Strains of Staphylococcus Aureus by Monoclonal Antibody to Toxic Shock Syndrome Toxin 1

The effectiveness of passive immunization was assessed in an infection model of toxic shock syndrome (TSS) in which monoclonal antibody to TSS toxin 1 (TSST-l) was administered intravenously to rabbits. Previously implanted infection chambers were inoculated with Staphylococcus aureus</it> strains RN4710 and D4508. The former strain carries the TSST-l gene on plasmid pRN6201; the latter is a TSST-l-negative clinical isolate obtained from a patient with nonmenstrual TSS. Purified monoclonal antibody, MAb 8-5-7 (IgG), was administered in two doses of ~ 1.25 mg each 24 hours before and 24 hours after infection. MAb 8-5-7 provided complete protection against both the TSS-like syndrome and the mortality that occurred in unprotected rabbits infected with strain RN4710 but did not provide complete protection in rabbits infected with strain D4508; three of the five rabbits either displayed signs of illness or died despite treatment. Western-blot analyses of the extracellular proteins produced by strains RN4710 and D4508 that used MAb 8-5-7 as a probe revealed that only TSST-l produced by RN4710 reacted with the antibody. Thus, if MAb 8-5-7 partially protected animals against infections with strain D4508, the protection appears to have been nonspecific.